Fish Oil and Vitamin D: study protocols
10 study groups took Fish Oil together with Vitamin D. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Fish Oil
10 study groups in 10 studies say how much Fish Oil participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 g to 2.5 g, 70% of 10 study groups.
| Daily dose | Study groups |
|---|---|
| 250 mg or less | 1 |
| 250 mg to 500 mg | 0 |
| 500 mg to 1 g | 2 |
| 1 g to 2.5 g | 7 |
Dose per serving from research: Vitamin D
7 study groups in 7 studies say how much Vitamin D participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 500 IU to 1,000 IU and 1,000 IU to 2,500 IU, 43% of 7 study groups each.
| Daily dose | Study groups |
|---|---|
| 250 IU or less | 1 |
| 250 IU to 500 IU | 0 |
| 500 IU to 1,000 IU | 3 |
| 1,000 IU to 2,500 IU | 3 |
Commonly used together
7 of 10 study groups took Fish Oil and Vitamin D with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Omega-3 Fatty Acids | 3 |
| Whey Protein | 3 |
10 study groups
| Study | ||||
|---|---|---|---|---|
| Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer 2019 · n-3 fatty acids plus vitamin D group · Men aged 50 years or older and women aged 55 years or older, without selection for cardiovascular risk factors, in a primary-prevention trial | 1 g | 2,000 IU | 1936 days | — |
| Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial 2022 · Vitamin D active/omega 3 active · Men aged 50 years or older and women aged 55 years or older; general older-adult population, not selected for vitamin D deficiency | 1 g | 2,000 IU | 5 years | — |
| The impact of supplemental n-3 long chain polyunsaturated fatty acids and dietary antioxidants on physical performance in postmenopausal women 2013 · n-3 LCPUFA group · Postmenopausal women over age 65 without the listed bone, cancer or liver diseases; most were prefrail or frail. | 1.2 g | 1,000 IU | 180 days | 85 |
| Effect of Omega-3 Polyunsaturated Fatty Acid Supplementation on Clinical Outcome of Atopic Dermatitis in Children 2024 · intervention group · Children aged 1–8 years with moderate-to-severe atopic dermatitis | 2 g | 5 mcg | 120 days | 26 |
| A Five-Ingredient Nutritional Supplement and Home-Based Resistance Exercise Improve Lean Mass and Strength in Free-Living Elderly 2020 · Muscle5 (M5) · Sedentary or low-active, free-living men aged 65 years or older, with normal to class 1/low-risk obesity and varying degrees of age-related muscle loss | 2.46 g | 1,000 IU | 12 weeks | 22 |
| Obesity and Metabolic Disease Impair the Anabolic Response to Protein Supplementation and Resistance Exercise: A Retrospective Analysis of a Randomized Clinical Trial with Implications for Aging, Sarcopenic Obesity, and Weight Management 2024 · Muscle 5 (M5) · Men aged 66–91 years; older, sedentary or low-active participants, with the subgroup analysis including overweight or obese men with at least one additional metabolic-syndrome risk factor | 2.46 g | 1,000 IU | 12 weeks | 16 |
| The Effect of Fish Oil, Vitamin D and Protein on URTI Incidence in Young Active People 2015 · supplementation · Young recreational athletes; age and sex not specified; healthy active population | 1.1 g | 10 mcg | 16 weeks | — |
| A randomised comparison of increase in serum 25-hydroxyvitamin D concentration after 4 weeks of daily oral intake of 10 microg cholecalciferol from multivitamin tablets or fish oil capsules in healthy young adults 2007 · fish oil capsules · Healthy adults aged 19–49 years | 10 mcg | 10 mcg | 4 weeks | 27 |
| Effects of dietary supplementation of fish oil plus vitamin D(3) on gut microbiota and fecal metabolites, and their correlation with nonalcoholic fatty liver disease risk factors: a randomized controlled trial 2024 · FO + D group · Subjects studied in relation to nonalcoholic fatty liver disease risk factors; age and sex not reported | 2.34 g | 1,680 IU | 90 days | — |
| Potential Modulation of Inflammation by Probiotic and Omega-3 Supplementation in Elderly with Chronic Low-Grade Inflammation-A Randomized, Placebo-Controlled Trial 2022 · Active treatment group · Adults aged 65–80 with low-grade inflammation (hs-CRP 1.5–6 mg/L) and BMI 18.5–27 kg/m² | 1.1 g | 200 IU | 8 weeks | — |